A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema

NCT01315275 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

394

Enrollment

INDUSTRY

Sponsor class

Conditions

Visual Impairment
Macular Edema

Interventions

DRUG: Ranibizumab

Sponsor

Novartis Pharmaceuticals